Patterson Companies

Patterson Cos., Inc. provides products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Patterson Companies Inc. reports strong Q4 performance and outlines growth strategies for fiscal 2024

Patterson Companies Inc. delivered strong financial results for Q4 2023, with a focus on sustained margin improvement and strategic growth opportunities. Despite challenges in free cash flow and market moderation, the company is well-positioned to leverage its strengths and capitalize on opportunities in the dental and animal health segments.

Patterson Companies Inc. reports strong Q2 earnings and focuses on private label growth

Patterson Companies Inc. delivered strong financial performance in Q2 2023, driven by growth in both the Dental and Animal Health segments. The company reaffirmed fiscal '24 earnings guidance and highlighted the potential of private label products. Despite tax and interest rate challenges, the company remains optimistic and focused on strategic initiatives to drive future growth.

Patterson Companies excels in Q3, eyes international growth opportunities

Patterson Companies reported a strong Q3 performance with internal sales growth and margin improvements. Challenges in the Dental segment were offset by growth in the Animal Health segment. The company highlighted strategic acquisitions, leadership appointments, and operational enhancements as key drivers of success. Opportunities lie in stable patient traffic, international investments, and exploring M&A in dental specialties for future growth.

Patterson Companies reports strong Q4 performance and strategic growth focus

Patterson Companies had a robust Q4 performance, showcasing growth in sales and margins. Despite challenges in the companion animal market, the company is strategically positioned for growth through software investments and service enhancements. Opportunities lie in sustained sales growth, margin expansion, and strategic market positioning.

Patterson Companies reports strong Q1 results amidst strategic focus

Patterson Companies delivered strong Q1 '24 results with growth in sales and adjusted EPS. The company is strategically focusing on private label products and efficiency improvements. While facing challenges like deflationary impacts and inflationary pressures, Patterson sees opportunities in Dental equipment growth and continued investments for long-term profitability.

Patterson Companies reports strong Q2 performance amidst market challenges

Patterson Companies delivered a solid performance in Q2 2024, driven by growth in Dental and Animal Health segments.
Despite challenges like macroeconomic headwinds and pricing pressures, the company remains focused on efficiency and driving demand.
Opportunities exist for Patterson to capitalize on market trends, optimize operations, and explore new growth avenues.
Investors should monitor how Patterson navigates challenges and leverages strengths to achieve its revised fiscal guidance.

Patterson Companies reports solid Q3 performance amidst market challenges

Patterson Companies delivered a solid performance in Q3 2024, with a focus on revenue growth, margin expansion, and strategic investments in distribution and software offerings.
While facing challenges in certain segments, the company remains committed to operational efficiency, margin integrity, and long-term growth initiatives.
Opportunities lie in sustaining sales growth, expanding market presence, and capitalizing on improvements in equipment demand and margin enhancement.
Overall, Patterson's strategic focus on growth, efficiency, and innovation positions the company for long-term success in the market.

Patterson Companies Reports Stable Q4, Eyes Strategic Growth

Patterson Companies concluded fiscal 2024 with stable financial performance, facing some headwinds in the Dental segment but offset by gains in Animal Health and strategic tech investments. The company is poised for modest growth in 2025, backed by ongoing investments in high-margin areas and a strong focus on innovation and market expansion.

Patterson Companies addresses challenges in Q1 2025 earnings call

Patterson Companies faced challenges in Q1 2025, with declines in both the Dental and Animal Health segments.
Despite these challenges, management is taking actions to improve performance and profitability for the rest of fiscal 2025.
The company's focus on cost management and operational efficiency is a strength in navigating the current environment.
Opportunities exist in strengthening the companion animal business, improving internal sales, and enhancing cybersecurity measures.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Patterson Cos., Inc. engages in the provision of products, technologies, services, and business solutions to the dental and animal health markets. It operates through the following segments: Dental, Animal Health, and Corporate. The Dental segment provides consumable dental products, equipment and software, turnkey digital solutions, and value-added services to dentists, dental laboratories, institutions, and other healthcare professionals. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets. The Corporate segment consists of general and administrative expenses, including home office support costs in areas such as information technology, finance, legal, human resources, and facilities. The company was founded by John Patterson and Myron Fayette Patterson in 1877 and is headquartered in St. Paul, MN.

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies (Nasdaq: PDCO) today announced that it will hold its fiscal 2024 second-quarter call on Wednesday, November 29, 2023, at 7:30 a.m. CT (8:30 a.m. ET). The company's earnings release will be issued that morning before the market opens. To access the live webcast, go to the investor relations section of the company's website, www.PattersonCompanies.com. The fiscal 2024 second-quarter earnings conference call replay will be available beginning a.

Patterson Companies Fiscal 2024 Second Quarter Conference Call Scheduled for Wednesday, November 29, 2023

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Are Investors Undervaluing Patterson Companies (PDCO) Right Now?

Merit Medical Systems

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Patterson Cos. (PDCO) or Merit Medical (MMSI).

PDCO or MMSI: Which Is the Better Value Stock Right Now?

Today, we take a look at Patterson Companies, Inc., which operates in both the dental and animal health sectors. The stock of this slow-growing, but somewhat recession-resistant, concern has a valuation significantly under the overall P/E on the S&P 500 and yields over 3.1%. An analysis around Patterson Companies follows in the paragraphs below.

The Prognosis For Patterson Companies

Patterson Cos. (PDCO) concluded the recent trading session at $30.87, signifying a +1.21% move from its prior day's close.

Patterson Cos. (PDCO) Ascends While Market Falls: Some Facts to Note

Envista Holdings Corp

Align Technology

Halloween has come and gone for another year.  Candy by the bag load was collected, sorted by parents and eaten by children and adults alike.

3 Stocks Primed to Get a Post-Halloween Lift

From a technical perspective, Patterson Cos. (PDCO) is looking like an interesting pick, as it just reached a key level of support.

Patterson Cos. (PDCO) Recently Broke Out Above the 20-Day Moving Average

Investors remain optimistic about Patterson Companies (PDCO) on the back of its broad product line.

Reasons to Add Patterson Companies (PDCO) in Your Portfolio Now

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why Patterson Cos. (PDCO) is a Strong Momentum Stock

PDCO vs. MMSI: Which Stock Is the Better Value Option?

Henry Schein

DENTSPLY SIRONA

Henry Schein has looked to mergers and acquisitions to add revenue growth. Dentsply Sirona grew quarterly earnings per share by 17.6% year over year in the second quarter.

3 Dental Supply Stocks You Can Sink Your Teeth Into

Patterson Cos. (PDCO) concluded the recent trading session at $30.34, signifying a -1.91% move from its prior day's close.

Patterson Cos. (PDCO) Falls More Steeply Than Broader Market: What Investors Need to Know

Celsius Holdings

Dominion Energy

Coca-Cola

Medtronic

Morgan Stanley

Visa

Investors are worried that the stock market's first-half performance in 2023 is reversing. It's unclear what part of the business cycle we are currently in.

7 Resilient Stocks Poised to Prosper in Any Market Condition

Why Patterson Cos. (PDCO) is a Top Momentum Stock for the Long-Term

AbbVie

Cardinal Health

CVS Health

Johnson & Johnson

UnitedHealth Group

Facing an uncertain market environment, investors ought to consider the top healthcare stocks that pay dividends. Sure, the Federal Reserve may be in a position to facilitate a soft landing for the economy, per bullish analysts.

7 Top Healthcare Stocks That Pay Dividends

Patterson Cos. (PDCO) reported earnings 30 days ago.

Why Is Patterson Cos. (PDCO) Down 1.1% Since Last Earnings Report?

Reasons to Retain Patterson Companies (PDCO) in Your Portfolio

Patterson Companies' (PDCO) first-quarter fiscal 2024 results reflect robust improvement in Dental Equipment sales, value-added services and Animal Health segment.

Patterson Companies (PDCO) Q1 Earnings In Line, Sales Hurt by FX

With shares up more than 30% over the past three months, Patterson Companies announced mixed fiscal first-quarter 2024 results. Earnings drove outsize growth thanks to margin-improvement initiatives.

Why Patterson Companies Stock Dropped Today

Patterson Companies, Inc. (NASDAQ:PDCO ) Q1 2024 Earnings Conference Call August 30, 2023 8:30 AM ET Company Participants John Wright - Vice President, Investor Relations Don Zurbay - President and Chief Executive Officer Kevin Barry - Chief Financial Officer Conference Call Participants Jason Bednar - Piper Sandler Nathan Rich - Goldman Sachs Jeff Johnson - Baird Kevin Caliendo - UBS John Block - Stifel Elizabeth Anderson - Evercore ISI A.J. Rice - Credit Suisse Allen Lutz - Bank of America John Stansell - JPMorgan Operator Good morning, and welcome to the Patterson Companies Inc., First Quarter Fiscal 2024 Earnings Conference Call.

Patterson Companies, Inc. (PDCO) Q1 2024 Earnings Call Transcript

Should Value Investors Buy Patterson Companies (PDCO) Stock?

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Patterson Cos. (PDCO) could be a great choice.

Despite Fast-paced Momentum, Patterson Cos. (PDCO) Is Still a Bargain Stock

Patterson Companies, Inc. (NASDAQ:PDCO) shares fell more than 6% in early trading on Wednesday after the animal and oral health markets solutions provider reported its first quarter fiscal 2024 financial results. Its sales for the period rose 3.5% year-over-year to $1.57 billion, matching the Street forecast per Zacks Consensus Estimate.

Patterson Companies shares fall despite reporting 1Q earnings in line with estimates

ST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.6 billion (see attached Sales Summary for further details) in its fiscal 2024 first quarter ended July 29, 2023, an increase of 3.5 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation and contributions from recent acquisitions, increased 2.8 percent over the prior year period. Reported net income attributable.

Patterson Companies Reports Fiscal 2024 First Quarter Operating Results

Patterson Companies (PDCO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

News for Patterson Companies Stock (PDCO)